Bancos genómicos en México: gobernanza pública, propiedad privada y la ética del acceso controlado
Latin american journal of clinical sciences and medical technology · 26.06.2026 · 8 (1) · 76-85
DOI: 10.34141/ljcs9425358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Latin american journal of clinical sciences and medical technology, erschienen am 26.06.2026. Verfasst von Gilberto Castañeda-Hernández und 21 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Recent genomic research from the Mexican Biobank (MXB) highlights the importance of large - scale population datasets for understanding genetic variation in Mexican and Hispanic populations. In parallel, the oriGen Project has emerged as another large - scale initiative to generate genomic data from Mexican adults, establishing one of the country’s largest genomic biobanks. Although both initiatives share the goal of expanding population genomics resources, they differ substantially in their institutional structures, governance frameworks, and data access models. While MXB operates within a public institutional framework, the oriGen Project is organized under a private governance model that includes irreversible consent provisions and international commercial sequencing partnerships. This perspective article examines the ethical, legal, and governance implications of these arrangements, particularly regarding genomic sovereignty and public interest. We argue that controlled - open access models managed by private entities, particularly when they incorporate high fees and exemption mechanisms whose eligibility, scope, approval criteria, coverage, and application are not fully public or auditable, can restrict local scientific participation and favor asymmetries in the appropriation of national genomic value.
Zitieren
APA
Castañeda-Hernández, G., Pérez-Campos, E., Hernández-Huerta, M. T., Mayoral, L. P. C., Moreno-Cabral, S., Sánchez-Vega, J. T., Regalado, D. L., Nájera-Segura, N. S., Gutiérrez-Delgado, F., Ortega, M. M. S., Ruíz, H. M., Campos, E. P., López, F. D. R., Mora-Guzmán, Z., Borrás-Enríquez, A. J., Ramírez-García, S. A., Elizarrarás-Rivas, J., Guerrero, L. D. C., Alpuche, J., …, & González, E. E. J. (2026). Bancos genómicos en México: gobernanza pública, propiedad privada y la ética del acceso controlado. Latin american journal of clinical sciences and medical technology, 8(1), 76-85. https://doi.org/10.34141/ljcs9425358
Vancouver
Castañeda-Hernández G, Pérez-Campos E, Hernández-Huerta MT, Mayoral LPC, Moreno-Cabral S, Sánchez-Vega JT, et al. Bancos genómicos en México: gobernanza pública, propiedad privada y la ética del acceso controlado. Latin american journal of clinical sciences and medical technology. 2026;8(1):76-85. doi:10.34141/ljcs9425358
BibTeX
@article{CastaedaHernndez2026,
author = {Castañeda-Hernández, Gilberto and Pérez-Campos, Eduardo and Hernández-Huerta, María Teresa and Mayoral, Laura Pérez Campos and Moreno-Cabral, Sonia and Sánchez-Vega, José Trinidad and Regalado, Daniel López and Nájera-Segura, Nahui Samanta and Gutiérrez-Delgado, Francisco and Ortega, María Magdalena Serrano and Ruíz, Héctor Martínez and Campos, Eduardo Pérez and López, Federico del Razo and Mora-Guzmán, Zoila and Borrás-Enríquez, Anahí Jobeth and Ramírez-García, Sergio Alberto and Elizarrarás-Rivas, Jesús and Guerrero, Lilian Dolores Chel and Alpuche, Juan and Aquino-Jarquín, Guillermo and Cabrera-Fuentes, Héctor Alejandro and González, Efrén Emmanuel Jarquín},
title = {Bancos genómicos en México: gobernanza pública, propiedad privada y la ética del acceso controlado},
journal = {Latin american journal of clinical sciences and medical technology},
year = {2026},
volume = {8},
number = {1},
pages = {76--85},
doi = {10.34141/ljcs9425358}
}
EUVIMED